Capital Fund Management (CFM)
IDXX icon

Capital Fund Management (CFM)’s Idexx Laboratories IDXX Stock Holding History

Capital Fund Management (CFM)’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-15,300
Closed -$6.69M – 2200
2023
Q3 		$6.69M Buy
+15,300
New +$7.63M 0.02% 794
2020
Q1 		– Sell
-800
Closed -$209K – 1779
2019
Q4 		$209K Sell
800
-2,200
-73% -$580K ﹤0.01% 1743
2019
Q3 		$816K Sell
3,000
-5,100
-63% -$1.42M 0.01% 1073
2019
Q2 		$2.23M Buy
8,100
+6,800
+523% +$1.68M 0.02% 773
2019
Q1 		$291K Sell
1,300
-5,500
-81% -$1.14M ﹤0.01% 1452
2018
Q4 		$1.26M Sell
6,800
-19,100
-74% -$3.92M 0.01% 1023
2018
Q3 		$6.47M Sell
25,900
-600
-2% -$146K 0.04% 663
2018
Q2 		$5.78M Buy
26,500
+17,300
+188% +$3.56M 0.03% 681
2018
Q1 		$1.76M Sell
9,200
-5,600
-38% -$1.03M 0.01% 1051
2017
Q4 		$2.31M Buy
14,800
+9,600
+185% +$1.51M 0.01% 938
2017
Q3 		$809K Buy
+5,200
New +$822K 0.01% 1040
2017
Q2 		– Sell
-1,800
Closed -$278K – 1578
2017
Q1 		$278K Buy
+1,800
New +$248K ﹤0.01% 1314
2013
Q3 		– Sell
-26,400
Closed -$1.19M – 1713
2013
Q2 		$1.19M Buy
+26,400
New +$1.15M 0.02% 755

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Capital Fund Management (CFM)'s IDXX Position: Q2 2026 in Review

Capital Fund Management (CFM) reduced its Idexx Laboratories (IDXX) stake by 21% in Q2 2026, selling an estimated $5.1M and leaving 33,791 shares worth $17.8M. The position accounts for 0.08% of the portfolio, ranked #368.

Capital Fund Management (CFM) first reported a position in IDXX in Q3 2014 and has held it in 26 quarters since. The position peaked at $30.6M in Q4 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Capital Fund Management (CFM) held 33,791 shares of Idexx Laboratories worth $17.8M as of Q2 2026.
  • Capital Fund Management (CFM) sold 9,098 Idexx Laboratories shares in Q2 2026, an estimated $5.1M.
  • Idexx Laboratories made up 0.08% of Capital Fund Management (CFM)'s portfolio in Q2 2026, its #368 holding.
  • Capital Fund Management (CFM) first reported a position in Idexx Laboratories in Q3 2014 and has held it in 26 quarters since.
  • Capital Fund Management (CFM)'s Idexx Laboratories position peaked at $30.6M in Q4 2025.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.